<ul data-eligibleForWebStory="false"><li>InGovern raised concerns over governance lapses and regulatory breaches regarding a grant of ESOPs worth over ₹400 crore to Dr. Rashmi Saluja, Chairperson of Religare Enterprises and Non-Executive Director at Care Health Insurance.</li><li>The Board of Care Health Insurance should disclose all communication with IRDAI regarding the ESOP grant and the rationale for proceeding despite regulatory rejection, as per the InGovern report.</li><li>Religare Enterprises stated that IRDAI found the issuance of ESOPs to Dr. Saluja illegal, leading to an appeal that was withdrawn after her removal from the Board.</li><li>The report also questioned potential conflicts of interest involving CHIL's key legal advisors and advised shareholders to seek further details on the matter.</li></ul>

InGovern raises concerns on regulatory lapses at Care Health Insurance

Discover more